Table 2 Mental health and HIV measures at baseline and 6-month follow-up, for participants with data at both time points (N = 93)a
|  | Standard of care (N = 38) | SYV Intervention (N = 55) | |||||
|---|---|---|---|---|---|---|---|
Baseline | 6-month | Change | Baseline | 6-month | Change | ||
PHQ-9f | Total score | 6.3 (4.1) | 5.1 (3.9) | − 0.9 (3.7) | 4.9 (3.3) | 4.1 (3.4) | − 0.8 (4.0) |
≥ 10b | 10 (27.0%) | 4 (11.1%) |  | 4 (7.3%) | 5 (9.1%) |  | |
SDQf | Total score | 7.1 (3.6) | 7.3 (4.4) | 0.1 (3.9) | 7.3 (4.0) | 6.7 (4.4) | − 0.6 (3.9) |
≥ 17b | 0 (0.0%) | 2 (5.6%) |  | 0 (0.0%) | 2 (3.6%) |  | |
UCLA Traumaf | Total score | 9.3 (6.9) | 8.9 (6.3) | −0.3 (5.9) | 8.6 (7.4) | 8.6 (7.5) | 0.0 (7.3) |
≥ 18b | 5 (13.5%) | 4 (10.8%) |  | 9 (16.4%) | 8 (14.5%) |  | |
Stigmaf Mean (SD) | Total Score | 23.5 (3.7) | 21.5 (5.1) | −2.3 (4.7) | 21.9 (5.1) | 22.7 (5.3) | 0.6 (4.2) |
Internal Score | 8.1 (1.8) | 7.1 (2.0) | −1.1 (1.7) | 7.7 (1.9) | 7.5 (2.1) | −0.2 (2.5) | |
External Score | 15.5 (3.7) | 14.3 (4.2) | −1.2 (3.9) | 14.4 (4.3) | 15.1 (4.5) | 0.7 (3.3) | |
Adherencef | Self-report Scored | 57.7 (15.2) | 57.7 (14.9) | −0.1 (12.4) | 60.5 (11.6) | 65.5 (12.3) | 5.1 (17.0)f |
ART concen-tration in Hair (ng/mg) | NVP (N = 13) | 44.2 (15.4) | 49.7 (20.8) | 5.4 (16.1) | 47.1 (19.2) | 45.9 (20.0) | 2.4 (32.2) f |
EFV (N = 29) | 9.3 (7.3) | 10.0 (8.2) | −1.1 (4.1) | 6.0 (5.4) | 5.7 (3.3) | −0.3 (4.8) | |
LPV (N = 15) | 6.1 (5.9) | 11.0 (11.7) | 4.9 (9.2) | 6.3 (6.6) | 6.9 (5.9) | 0.6 (6.5) f | |
ATV (N = 20) | 4.7 (4.0) | 4.4 (3.2) | −0.4 (2.3) | 5.8 (3.8) | 6.1 (3.1) | 0.4 (1.7) f | |
|  | Standardized (N = 77)e | −0.4 (2.0) | −0.5 (2.0) | − 0.1 (1.5) | −0.7 (2.3) | − 0.6 (1.7) | 0.1 (2.1) f |
Viral Load Copies/mL | Total Score Log10 | 5.1 (2.8) | 5.3 (3.3) | 0.2 (1.8) | 5.4 (3.3) | 4.7 (2.6) | −0.7 (2.5) |
Virologic Suppressionb (<400 copies/mL) | 25 (65.8%) | 25 (65.8%) |  | 35 (64.8%) | 41 (74.5%) |  | |